JUPITER NEUROSCIENCES, INC. Diluted Shares Outstanding (Weighted Average)
JUPITER NEUROSCIENCES, INC. (JUNS) reported Diluted Shares Outstanding (Weighted Average) of 557.57 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 557.57K shares, a 26.03% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 35.26M shares, a 6.50% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 38.18M shares, a 20.66% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 34.04M shares, a 9.57% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 34.63M shares, a 20.31% increase from fiscal 2024.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 28.78M shares, a 9.01% increase from fiscal 2023.
- JUPITER NEUROSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 26.41M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 557.57K shares 10-Q · filed 2026-08-14 | 514.06K shares 10-Q · filed 2026-08-14 | 24.66M shares derived: average of 3 quarters · filed 2026-08-14 | 27.01M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | 35.26M shares 10-Q · filed 2026-05-14 | 36.72M shares derived: average of 2 quarters · filed 2026-05-14 | 35.82M shares derived: average of 3 quarters · filed 2026-05-14 | 26.98M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | 38.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 36.11M shares derived: average of 2 quarters · filed 2026-04-01 | 24.22M shares derived: average of 3 quarters · filed 2026-08-14 | 34.63M shares 10-K · filed 2026-04-01 | ||
| 2025-09-30 | 34.04M shares 10-Q · filed 2025-11-14 | 17.24M shares derived: average of 2 quarters · filed 2026-08-14 | 33.45M shares 10-Q · filed 2025-11-14 | 24.81M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | 442.41K shares 10-Q · filed 2026-08-14 | 33.18M shares 10-Q · filed 2025-08-19 | 445.26K shares 10-Q · filed 2026-08-14 | 33.39M shares 10-Q · filed 2025-08-19 | 21.73M shares derived: average of 3 quarters · filed 2026-08-14 | 24.06M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 33.10M shares 10-Q · filed 2026-05-14 | 32.37M shares derived: average of 2 quarters · filed 2026-05-14 | 31.94M shares derived: average of 3 quarters · filed 2026-05-14 | 31.60M shares derived: average of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | 31.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 31.35M shares derived: average of 2 quarters · filed 2026-04-01 | 31.10M shares derived: average of 3 quarters · filed 2026-04-01 | 28.78M shares 10-K · filed 2026-04-01 | ||
| 2024-09-30 | 31.07M shares 10-Q · filed 2025-11-14 | 30.83M shares derived: average of 2 quarters · filed 2025-11-14 | 27.83M shares 10-Q · filed 2025-11-14 | 28.65M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 30.59M shares 10-Q · filed 2025-08-19 | 27.25M shares 10-Q · filed 2025-08-19 | 27.85M shares derived: average of 3 quarters · filed 2025-08-19 | 27.49M shares derived: average of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | 26.53M shares 10-Q · filed 2025-05-15 | 26.48M shares derived: average of 2 quarters · filed 2025-05-15 | 26.45M shares derived: average of 3 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 26.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 26.42M shares derived: average of 2 quarters · filed 2025-03-28 | 26.41M shares 10-K · filed 2025-03-28 | |||
| 2023-09-30 | 26.40M shares 10-Q · filed 2024-12-23 | 26.40M shares 10-Q · filed 2024-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |